Quasar Engineering Ltd.

Based in Hong Kong, Quasar Engineering Ltd. specializes in manufacturing high-quality minimally invasive medical devices, focusing on advanced balloon catheters and microsensors for various medical applications. Quasar Engineering Ltd. is a manufacturer of innovative medical devices formed in 1988, headquartered in Hong Kong.

The company was founded by Michel Pichon, who has a history of founding multiple ventures. In July 2023, Quasar secured a funding round of USD 600. 00 mn in a Secondary Buyout led by Boyu Capital, marking a pivotal moment in its growth strategy. The company has participated in 2 deals to date, with its most recent deal occurring on July 17, 2023.

Quasar is a leading manufacturer of high-quality minimally invasive medical devices, specializing in advanced balloon catheters, microsensors, and various components essential for medical applications. Their core product offerings include innovative catheter balloons designed for structural heart, cardio, neurovascular, and peripheral interventions, as well as a wide range of braided catheter shaft solutions tailored to specific device requirements. Quasar also provides full turnkey sensor solutions that leverage their expertise in complex electromagnetic sensors, enhancing the functionality of sensing catheters. Their products cater to a diverse client base, including global OEMs in the medical device sector, with a focus on markets across North America, Europe, and Asia.

Through their vertically integrated solutions and comprehensive manufacturing capabilities, Quasar facilitates efficient production processes and rapid prototyping, ensuring that healthcare providers receive timely and effective medical solutions. Quasar's revenue generation model relies on B2B transactions, primarily serving OEM partners in the medical device industry. The company engages in direct partnerships with these clients to supply a range of medical devices and components, utilizing structured agreements that allow for customized product offerings based on specific needs. Transactions typically involve bulk orders of their flagship products, such as advanced balloon catheters and microsensors, with pricing determined by project specifications and manufacturing complexity.

Quasar's commitment to quality and innovation ensures long-term relationships with clients, who often rely on them for comprehensive assembly and production services. Additionally, their ISO 13485 certified quality systems contribute to a robust reputation, enhancing client confidence in their products and services. In July 2023, Boyu Capital agreed to fully acquire Quasar Engineering Ltd. for approximately USD 600.

00 mn. This acquisition is expected to enhance Quasar's capacity to expand its medical devices manufacturing and continuously reach its global healthcare customers. The company plans to introduce new products, including advanced catheter solutions that are currently under development, aimed at penetrating emerging markets in Asia and Europe by the end of 2025.